| Literature DB >> 30374695 |
Paulina J M Bank1, Marina A Cidota2,3, P Elma W Ouwehand4, Stephan G Lukosch2.
Abstract
In clinical practice, upper extremity motor impairments are commonly assessed with disease-specific, subjectively scored and low-resolution rating scales that often do not consider the variations in tasks and environment that are essential aspects of daily life. Augmented reality (AR) systems with contactless tracking of the hand and upper body offer opportunities for objective quantification of motor (dys)function in a challenging, engaging and patient-tailored environment. In this study, we explore the potential of AR for evaluating 1) speed and goal-directedness of movements within the individually determined interaction space, 2) adaptation of hand opening to objects of different sizes, and 3) obstacle avoidance in healthy individuals (N = 10) and two highly prevalent neurological conditions (N = 10 patients with Parkinson's Disease and N = 10 stroke patients). We successfully implemented three AR games to evaluate these key aspects of motor function. As expected, PD patients moved slower than controls and needed more time for task completion. No differences were observed between stroke patients and controls, perhaps because motor impairments in this patient group were relatively mild. Importantly, usability of our AR system was good and considerably improved compared to our previous study due to more natural and patient-tailored interaction. Although our findings testify to the potential of AR for assessing motor impairments in patients with neurological conditions and provide starting points for further improvement, there are still many steps to be taken towards application in clinical practice.Entities:
Keywords: Augmented reality; Engagement; Motor function; Parkinson’s disease; Stroke; Upper extremity
Mesh:
Year: 2018 PMID: 30374695 PMCID: PMC6208648 DOI: 10.1007/s10916-018-1100-9
Source DB: PubMed Journal: J Med Syst ISSN: 0148-5598 Impact factor: 4.460
Participant characteristics
| Controls | PD patients | Stroke patients | |
|---|---|---|---|
| 10 | 10 | 10 | |
| Sex (male/female) | 6 / 4 | 6 / 4 | 6 / 4 |
| Age (yr) (mean, SD) a | 61.6 ± 6.8 | 60.8 ± 7.5 | 60.5 ± 7.0 |
| Disease duration (yr) (median, IQR) | – | 11.9 [7.4–15.7] | 3.5 [1.9–9.1] |
| Tested side (dominant/non-dominant) | 5 / 5 | 6 / 4 | 6 / 4 |
| MoCA (median, IQR) b | 28.5 [27.5–29.3] | 27.5 [25.8–29.3] | 26.0 [24.8–27.3] * |
| PD-specific clinical characteristics | |||
| Stereotactic surgery (yes/no) | – | 3 / 7 | – |
| Hoehn and Yahr stage (median, range) c | – | 2 [ | – |
| SPES/SCOPA total score (mean, SD) d | – | 18.1 ± 4.6 | – |
| Stroke-specific clinical characteristics | |||
| First ever stroke (%) | – | – | 90 |
| Type of stroke (ischemic/hemorrhage) | – | – | 9 / 1 |
| Lesion side (left/right/both) | – | – | 6 / 4 / 0 |
| Modified Rankin Scale (median, range) e | – | – | 1.5 [ |
| Fugl-Meyer Upper Extremity Scale (median, IQR) f | – | – | 59.5 [55.8–64] |
a Not significantly different between PD patients and controls (t(18) = 0.25, P = .81) or between stroke patients and controls (t(18) = 0.37, P = .71). b MoCA = Montreal Cognitive Assessment; 0–30; high: better [24]; * significantly reduced compared to controls (P = .01). One control, two PD patients, and four stroke patients scored <26 (cutoff for mild cognitive impairment); c 0–5; high: worse [17]; d SPES/SCOPA motor examination, total score: 0–63; high: worse [18]; e 0–5; high: worse [19]; f 0–66; high: better [20]; range of observed scores = 43–65
Fig. 1Impression of a participant during the experiment, with a close-up view of the optical see-through HMD with Leap Motion and webcam mounted on top of it. The laptop screen displayed a copy of the stereo images that were presented to the participant’s left and right eye in the HMD
Fig. 2Impression of the three AR games. (a) first part of game 1: “Balloons”; (b) second part of game 1: “Balloons”; (c) game 2: “Melody cubes”; (d) game 3: “Hungry squirrel”. The dark grey background of these screen captures appears almost transparent in the HMD so that the participant’s real hand and real environment are visible together with the virtual content
Significant statistical results for game outcome measures and user experiences
| Outcome | Effect | PD patients versus controls | Stroke patients versus controls | ||||
|---|---|---|---|---|---|---|---|
| Test statistic | Effect size | Test statistic | Effect size | ||||
| Game 1: Balloons | |||||||
| Maximum reach distance (MRD) [%]a,d | Q | .007 | .21 | .01 | .19 | ||
| G | .04 | .23 | – | ||||
| Success rate [%] e | G | – | – | ||||
| Tballoon [s]f,g | G | – | – | ||||
| Movement speed [cm/s]f | G | – | – | ||||
| Relative path length [–]f, g | G | – | – | ||||
| Game 2: Melody Cubes | |||||||
| | CS | <.001 | .44 | .02 | .20 | ||
| G | – | – | |||||
| | CS | <.001 | .55 | <.001 | .54 | ||
| G | – | – | |||||
| | CS | <.001 | .56 | <.001 | .61 | ||
| G | – | – | |||||
| Movement speed [cm/s] d | CS | .01 | .23 | .02 | .19 | ||
| G | .02 | .27 | – | ||||
| Number of interaction episodes d | CS | <.001 | .43 | <.001 | .45 | ||
| G | – | – | |||||
| Game 3: Hungry Squirrel | |||||||
| Success rate [%] e | G | – | – | ||||
| | S | .01 | .30 | .02 | .30 | ||
| G | .04 | .21 | – | ||||
| Movement speed [cm/s] b,d | S | <.001 | .62 | <.001 | .57 | ||
| TP | – | .04 | .22 | ||||
| G | .004 | .37 | – | ||||
| Relative path length [−] b,d,g | S | .004 | .44 | .01 | .35 | ||
| TP | .02 | .29 | .02 | .30 | |||
| S × TP | – | .02 | .32 | ||||
| G | .004 | .43 | – | ||||
| S × G | – | .05 | .22 | ||||
| User experiences | |||||||
| Workload (NASA-TLX) d | GA | .03 | .19 | – | |||
| G | – | – | |||||
| Engagement (GEQ-subset) d | GA | .01 | .22 | – | |||
| G | – | – | |||||
| Usability (SUS) f | G | – | – | ||||
| Presence f | G | – | – | ||||
G = group (PD vs. control, stroke vs. control; as indicated); Q = quadrant (ipsilateral upper, ipsilateral lower, contralateral upper and contralateral lower; only for maximum reach distance); CS = cube size (5 cm, 7.5 cm, 10 cm; only for game 2); S = scenario (no obstacle (NO) vs. visible obstacle (VO); only for game 3); TP = target position (upper vs. lower; only for game 3); GA = game (1, 2, 3; only for questionnaires on user experience). Comparisons were based on N = 10 controls, N = 10 PD patients and N = 10 stroke patients, unless indicated otherwise. a Based on N = 10 controls, N = 9 PD patients and N = 9 stroke patients, due to technical issues with Kinect; b Based on N = 10 controls, N = 10 PD patients and N = 9 stroke patients, because no data was available for the upper target (scenario VO) for one stroke patient who skipped the final five movements towards the upper target (too burdensome); c Based on N = 9 controls, N = 8 PD patients and N = 9 stoke patients, who successfully avoided at least one obstacle per target position in scenario VO; d Mixed ANOVAs, effect size quantified as partial eta squared (η); e Mann-Whitney U-tests; f Independent t-tests; g values were 10log transformed for statistical analysis
Fig. 3Results of the second part of game 1: “Balloons”. Error bars represent standard deviations. No significant group differences were detected
Fig. 4Results of game 2: “Melody cubes”. Error bars represent standard deviations. Symbols indicate significant differences (P < .05) between cube sizes (* PD/control analysis, + stroke/control analysis). Dotted lines in panels b and c indicate the actual size of the virtual cubes. Only for movement speed (panel e) a significant effect of group was observed, with PD patients moving slower than controls
Fig. 5Results of game 3 “Hungry squirrel”. Error bars represent standard deviations. Symbols indicate significant differences (P < .05) between scenarios (NO: no obstacle vs. VO: visible obstacle; * PD/control analysis, + stroke/control analysis), and between target positions (upper vs. lower; ♦ PD/control analysis ◊ stroke/control analysis). For all three outcome measures a significant effect of group was observed: compared to controls, PD patients needed more time (panel a), moved slower (panel b) and had a longer relative path length (panel c). Only in stroke patients the relative path length was not affected by the presence of an obstacle (panel c)